Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
WDR65	149465	broad.mit.edu	37	1	43665064	43665064	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr1:43665064T>A	ENST00000372492.4	+	9	1756	c.1432T>A	c.(1432-1434)Tcc>Acc	p.S478T	WDR65_ENST00000528956.1_Missense_Mutation_p.S478T|RNA5SP46_ENST00000362370.1_RNA	NM_001195831.2	NP_001182760.2	Q96MR6	WDR65_HUMAN	WD repeat domain 65	478		NA		NA						NS(1)|breast(2)|central_nervous_system(1)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(4)|lung(7)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	23	Acute lymphoblastic leukemia(166;0.155)	Myeloproliferative disorder(586;0.0505)				CCTATAGTGTTCCTTTAGCAA	0.463	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													242	201	215	NA		NA	NA	1		NA											NA				43665064		2203	4300	6503	SO:0001583	missense	NA	NA	ENSG00000243710	HGNC:26485	NM_152498	Approved	uc021omk.1	NA	A6NKQ3|Q17RI9|Q5TAI0	ENST00000372492.4	37		.	.	.	.	.	.	.	.	.	.	T	14.82	2.648372	0.47258	.	.	ENSG00000243710	ENST00000372492;ENST00000528956	T;T	0.40225	1.04;3.24	5.4	-10.8	0.00216	WD40/YVTN repeat-like-containing domain (1);Quinonprotein alcohol dehydrogenase-like (1);	0.853630	0.10682	N	0.646266	T	0.25005	0.0607	L	0.37750	1.13	0.09310	N	0.999996	B;B	0.14012	0.001;0.009	B;B	0.21360	0.002;0.034	T	0.27606	-1.0069	10	0.15952	T	0.53	.	13.5836	0.61917	0.0697:0.0599:0.6607:0.2097	.	478;478	Q96MR6;Q96MR6-2	WDR65_HUMAN;.	T	478	ENSP00000361570:S478T;ENSP00000435310:S478T	ENSP00000361570:S478T	S	+	1	0	WDR65	43437651	0.097000	0.21791	0.086000	0.20670	0.922000	0.55478	0.536000	0.23129	-1.711000	0.01395	-0.488000	0.04728	TCC	WDR65-002	NOVEL	not_organism_supported|basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000384325.1	256.814874	KEEP	NA	+	260.312621	0.37247	92	155	---	---	---	---	1	1	236	302	0	624	109	175	0	303	2	TP
FCRL1	115350	broad.mit.edu	37	1	157771270	157771270	+	Silent	SNP	G	G	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr1:157771270G>A	ENST00000368176.3	-	6	1051	c.984C>T	c.(982-984)taC>taT	p.Y328Y	FCRL1_ENST00000489998.1_Intron|FCRL1_ENST00000491942.1_Silent_p.Y328Y|FCRL1_ENST00000358292.3_Intron	NM_001159398.1|NM_052938.4	NP_001152870.1|NP_443170.1	Q96LA6	FCRL1_HUMAN	Fc receptor-like 1	328		NA		NA		integral to membrane|plasma membrane	receptor activity			breast(2)|cervix(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(1)|lung(24)|ovary(4)|prostate(1)|skin(6)	42	all_hematologic(112;0.0378)		LUSC - Lung squamous cell carcinoma(543;0.24)			TTTTGAGGCCGTAGCAAAATA	0.433	NA	NA		NA		NA		NA	NA	NA	NA	NA	G	1	5e-04	NA	0.0028	2184	NA	0.9999	,	,	NA	3e-04	NA	NA	NA	5e-04	0.8803	EXOME	NA	NA	2e-04	SNP	GBM(54;482 1003 11223 30131 35730)	NA			NA			NA				0								G	,,	0,4406		0,0,2203	73	74	73	NA	,984,984	-1.3	0.6	1		73	1,8599	1.2+/-3.3	0,1,4299	no	intron,coding-synonymous,coding-synonymous	FCRL1	NM_001159397.1,NM_001159398.1,NM_052938.4	,,	0,1,6502	AA,AG,GG	NA	0.0116,0.0,0.0077	,,	,328/429,328/430	157771270	1,13005	2203	4300	6503	SO:0001819	synonymous_variant	NA	NA	ENSG00000163534	HGNC:18509	NM_052938	Approved	uc001frg.3	NA	B2RE05|Q8N759|Q8NDI0|Q96PJ6	ENST00000368176.3	37	CCDS1170.1																																																																																			FCRL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000051401.1	107.207711	KEEP	NA	-	109.531691	0.345455	38	72	---	---	---	---	1	1	592	885	2	1040	41	81	0	131	10	TP
KDM3A	55818	broad.mit.edu	37	2	86702031	86702031	+	Silent	SNP	G	G	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr2:86702031G>A	ENST00000409556.1	+	13	2222	c.1857G>A	c.(1855-1857)aaG>aaA	p.K619K	KDM3A_ENST00000485171.1_3'UTR|KDM3A_ENST00000312912.5_Silent_p.K619K|KDM3A_ENST00000409064.1_Silent_p.K619K|KDM3A_ENST00000542128.1_Silent_p.K567K			Q9Y4C1	KDM3A_HUMAN	lysine (K)-specific demethylase 3A	619		NA		NA	androgen receptor signaling pathway|cell differentiation|formaldehyde biosynthetic process|histone H3-K9 demethylation|hormone-mediated signaling pathway|positive regulation of transcription, DNA-dependent|spermatogenesis|transcription, DNA-dependent	cytoplasm|nucleus	androgen receptor binding|iron ion binding|oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen			NS(1)|breast(3)|central_nervous_system(2)|endometrium(5)|kidney(5)|large_intestine(7)|liver(1)|lung(13)|ovary(1)|prostate(3)|skin(1)|stomach(3)|upper_aerodigestive_tract(2)	47						ACACAGCAAAGTACATCTTGG	0.408	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(96;1150 1523 6936 46253 49736)	NA			NA			NA				0													227	201	210	NA		NA	NA	2		NA											NA				86702031		2203	4300	6503	SO:0001819	synonymous_variant	NA	NA	ENSG00000115548	HGNC:20815	NM_018433	Approved	uc010ytj.2	NA	D6W5M3|Q53S72|Q68D47|Q68UT9|Q6N050|Q8IY08	ENST00000409556.1	37	CCDS1990.1																																																																																			KDM3A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252522.2	-6.106503	KEEP	NA	+	45.858936	0.069853	19	253	---	---	---	---	1	1	93	1545	1	1656	25	281	0	325	6	TP
TTN	7273	broad.mit.edu	37	2	179414490	179414490	+	Silent	SNP	G	G	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr2:179414490G>A	ENST00000589042.1	-	338	92183	c.91959C>T	c.(91957-91959)acC>acT	p.T30653T	TTN-AS1_ENST00000592750.1_RNA|TTN-AS1_ENST00000592689.1_RNA|TTN-AS1_ENST00000591332.1_RNA|TTN_ENST00000591111.1_Silent_p.T29012T|TTN-AS1_ENST00000590932.1_RNA|TTN-AS1_ENST00000590807.1_RNA|TTN-AS1_ENST00000586831.1_RNA|TTN_ENST00000342175.6_Silent_p.T21780T|TTN-AS1_ENST00000586707.1_RNA|TTN-AS1_ENST00000586452.1_RNA|TTN-AS1_ENST00000585451.1_RNA|RP11-65L3.2_ENST00000603415.1_RNA|TTN_ENST00000460472.2_Silent_p.T21588T|TTN-AS1_ENST00000456053.1_RNA|TTN-AS1_ENST00000592630.1_RNA|TTN-AS1_ENST00000438095.1_RNA|TTN_ENST00000342992.6_Silent_p.T28085T|TTN-AS1_ENST00000419746.1_RNA|TTN_ENST00000359218.5_Silent_p.T21713T|TTN-AS1_ENST00000592600.1_RNA	NM_001267550.1	NP_001254479.1	Q8WZ42	TITIN_HUMAN	titin	29012	Fibronectin type-III 123.	NA		NA			ATP binding|nucleic acid binding|protein serine/threonine kinase activity|protein tyrosine kinase activity			NS(24)|autonomic_ganglia(1)|breast(64)|central_nervous_system(14)|cervix(14)|endometrium(96)|haematopoietic_and_lymphoid_tissue(16)|kidney(91)|large_intestine(303)|liver(1)|lung(595)|ovary(58)|pancreas(17)|prostate(38)|skin(60)|stomach(29)|upper_aerodigestive_tract(1)|urinary_tract(26)	1448			OV - Ovarian serous cystadenocarcinoma(117;0.023)|Epithelial(96;0.0454)|all cancers(119;0.134)			TGATGTAGTGGGTTATGGGAG	0.448	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													132	118	123	NA		NA	NA	2		NA											NA				179414490		1893	4113	6006	SO:0001819	synonymous_variant	NA	NA	ENSG00000155657	HGNC:12403	NM_133378	Approved	uc031rqd.1	NA	E7ET18	ENST00000589042.1	37	CCDS59435.1																																																																																			TTN-018	PUTATIVE	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000450680.2	5.072966	KEEP	NA	-	27.007977	0.086614	11	116	---	---	---	---	1	1	57	1090	2	1461	11	123	1	133	7	TP
IDH1	3417	broad.mit.edu	37	2	209113113	209113113	+	Missense_Mutation	SNP	G	G	C	rs121913499		GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr2:209113113G>C	ENST00000415913.1	-	4	775	c.394C>G	c.(394-396)Cgt>Ggt	p.R132G	IDH1_ENST00000345146.2_Missense_Mutation_p.R132G|IDH1_ENST00000446179.1_Missense_Mutation_p.R132G			O75874	IDHC_HUMAN	isocitrate dehydrogenase 1 (NADP+), soluble	132		NA	R -> C (in colorectal cancer and glioma samples; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha- ketoglutarate but instead alpha- ketoglutarate is converted to R(-)-2- hydroxyglutarate).|R -> G (in a glioma sample; glioblastoma multiforme; somatic mutation).|R -> H (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> L (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).|R -> S (in a glioma sample; glioblastoma multiforme; somatic mutation; abolishes magnesium binding and alters enzyme activity so that isocitrate is no longer converted to alpha-ketoglutarate but instead alpha-ketoglutarate is converted to R(-)-2-hydroxyglutarate).	NA	2-oxoglutarate metabolic process|cellular lipid metabolic process|glyoxylate cycle|isocitrate metabolic process|NADPH regeneration|tricarboxylic acid cycle	cytosol|peroxisomal matrix	isocitrate dehydrogenase (NADP+) activity|magnesium ion binding|NAD binding|protein homodimerization activity	p.R132C(446)|p.R132G(125)|p.R132S(106)|p.G131_R132>VL(1)|p.R132V(1)		NS(1)|autonomic_ganglia(2)|biliary_tract(24)|bone(237)|central_nervous_system(3764)|endometrium(3)|haematopoietic_and_lymphoid_tissue(794)|kidney(2)|large_intestine(7)|lung(7)|prostate(6)|skin(5)|soft_tissue(12)|thyroid(22)|urinary_tract(1)	4887				Epithelial(149;0.0322)|LUSC - Lung squamous cell carcinoma(261;0.0711)|Lung(261;0.136)		TAAGCATGACGACCTATGATG	0.398	NA	NA	Mis	NA	gliobastoma	NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(158;264 1958 3300 35450 36047)	NA	Dom	yes	NA	2	2q33.3	3417	"""isocitrate dehydrogenase 1 (NADP+), soluble"""		O	679	Substitution - Missense(678)|Complex - compound substitution(1)	haematopoietic_and_lymphoid_tissue(280)|central_nervous_system(181)|bone(177)|biliary_tract(21)|soft_tissue(12)|large_intestine(2)|skin(2)|autonomic_ganglia(1)|endometrium(1)|NS(1)|prostate(1)											81	74	76	NA		NA	NA	2		NA											NA				209113113		2203	4300	6503	SO:0001583	missense	NA	NA	ENSG00000138413	HGNC:5382		Approved	uc002vcu.3	NA	Q7Z3V0|Q93090|Q9NTJ9|Q9UKW8	ENST00000415913.1	37	CCDS2381.1	.	.	.	.	.	.	.	.	.	.	G	22.4	4.286370	0.80803	.	.	ENSG00000138413	ENST00000345146;ENST00000446179;ENST00000415913;ENST00000415282	D;D;D;D	0.86956	-2.19;-2.19;-2.19;-2.19	5.57	5.57	0.84162	Isopropylmalate dehydrogenase-like domain (2);	0.000000	0.85682	D	0.000000	D	0.96636	0.8902	H	0.99379	4.54	0.80722	D	1	D	0.57899	0.981	P	0.62813	0.907	D	0.98312	1.0524	10	0.87932	D	0	-20.0399	19.5341	0.95242	0.0:0.0:1.0:0.0	.	132	O75874	IDHC_HUMAN	G	132	ENSP00000260985:R132G;ENSP00000410513:R132G;ENSP00000390265:R132G;ENSP00000391075:R132G	ENSP00000260985:R132G	R	-	1	0	IDH1	208821358	1.000000	0.71417	0.999000	0.59377	0.994000	0.84299	7.074000	0.76791	2.616000	0.88540	0.555000	0.69702	CGT	IDH1-006	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336672.1	130.774892	KEEP	NA	-	133.236844	0.344828	40	76	---	---	---	---	1	1	101	147	0	60	43	81	0	133	2	TP
DOCK10	55619	broad.mit.edu	37	2	225729691	225729691	+	Silent	SNP	C	C	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr2:225729691C>A	ENST00000409592.3	-	12	1466	c.1353G>T	c.(1351-1353)ggG>ggT	p.G451G	DOCK10_ENST00000258390.7_Silent_p.G457G			Q96BY6	DOC10_HUMAN	dedicator of cytokinesis 10	457		NA		NA			GTP binding			NS(1)|breast(3)|cervix(1)|endometrium(6)|kidney(10)|large_intestine(16)|lung(40)|ovary(2)|pancreas(1)|prostate(2)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(1)	87		Renal(207;0.0113)|all_lung(227;0.0486)|Lung NSC(271;0.0653)|all_hematologic(139;0.14)		Epithelial(121;2.37e-10)|all cancers(144;2.26e-07)|Lung(261;0.0143)|LUSC - Lung squamous cell carcinoma(224;0.0178)		CCACAGAAGCCCCCAAGAGCA	0.458	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													155	150	152	NA		NA	NA	2		NA											NA				225729691		1934	4149	6083	SO:0001819	synonymous_variant	NA	NA	ENSG00000135905	HGNC:23479		Approved	uc010fwz.1	NA	O75178|Q9NW06|Q9NXI8	ENST00000409592.3	37																																																																																				DOCK10-002	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000331158.2	-55.462247	KEEP	NA	-	14.213334	0.028169	8	276	---	---	---	---	1	0.9999998	29	1004	0	818	11	305	0	309	2	TP
SLC4A4	8671	broad.mit.edu	37	4	72319251	72319251	+	Silent	SNP	G	G	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr4:72319251G>A	ENST00000340595.3	+	9	1426	c.1230G>A	c.(1228-1230)gcG>gcA	p.A410A	SLC4A4_ENST00000512686.1_Silent_p.A410A|SLC4A4_ENST00000425175.1_Silent_p.A454A|SLC4A4_ENST00000351898.6_Silent_p.A454A|SLC4A4_ENST00000514331.1_3'UTR|SLC4A4_ENST00000264485.5_Silent_p.A454A	NM_003759.3	NP_003750.1	Q9Y6R1	S4A4_HUMAN	solute carrier family 4 (sodium bicarbonate cotransporter), member 4	454		NA		NA		basolateral plasma membrane|integral to plasma membrane	inorganic anion exchanger activity|protein binding|sodium:bicarbonate symporter activity			breast(3)|central_nervous_system(1)|cervix(1)|endometrium(6)|kidney(2)|large_intestine(9)|liver(1)|lung(21)|ovary(3)|pancreas(1)|prostate(1)|skin(6)|upper_aerodigestive_tract(2)|urinary_tract(1)	58			Lung(101;0.0739)|LUSC - Lung squamous cell carcinoma(112;0.225)			AGAGGAAAGCGCCATTTTTTG	0.343	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													201	204	203	NA		NA	NA	4		NA											NA				72319251		2203	4300	6503	SO:0001819	synonymous_variant	NA	NA	ENSG00000080493	HGNC:11030	NM_003759	Approved	uc010iic.3	NA	C4B714|O15153|Q8NEJ2|Q9H262|Q9NRZ1|Q9UIC0|Q9UIC1|Q9UP50	ENST00000340595.3	37	CCDS3549.1																																																																																			SLC4A4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252158.2	-27.58487	KEEP	NA	+	44.065607	0.05949	21	332	---	---	---	---	1	1	32	452	0	494	26	387	1	411	2	TP
SLCO6A1	133482	broad.mit.edu	37	5	101813473	101813473	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr5:101813473T>C	ENST00000506729.1	-	3	880	c.709A>G	c.(709-711)Act>Gct	p.T237A	SLCO6A1_ENST00000389019.3_Intron|SLCO6A1_ENST00000514551.1_Intron|SLCO6A1_ENST00000379807.3_Missense_Mutation_p.T237A|SLCO6A1_ENST00000379810.1_Intron|SLCO6A1_ENST00000513675.1_Intron			Q86UG4	SO6A1_HUMAN	solute carrier organic anion transporter family, member 6A1	237		NA		NA		integral to membrane|plasma membrane	transporter activity			breast(1)|central_nervous_system(1)|endometrium(2)|kidney(2)|large_intestine(17)|lung(22)|ovary(3)|prostate(4)|skin(6)|upper_aerodigestive_tract(1)|urinary_tract(1)	60		all_cancers(142;8e-09)|all_epithelial(76;2.83e-12)|Prostate(80;0.00125)|Colorectal(57;0.00342)|Ovarian(225;0.024)|Lung NSC(167;0.0259)|all_lung(232;0.0323)		Epithelial(69;1.47e-15)|COAD - Colon adenocarcinoma(37;0.0113)		CCCTGCACAGTCTGCCCAAGG	0.393	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													171	163	165	NA		NA	NA	5		NA											NA				101813473		2203	4300	6503	SO:0001583	missense	NA	NA	ENSG00000205359	HGNC:23613	NM_173488	Approved	uc003knp.3	NA	A6NHC1|Q6ZMY5|Q86UV2|Q8IYU5	ENST00000506729.1	37	CCDS34206.1	.	.	.	.	.	.	.	.	.	.	T	8.466	0.856373	0.17106	.	.	ENSG00000205359	ENST00000506729;ENST00000379807	T;T	0.79454	-1.27;-1.27	4.93	-4.1	0.03940	Major facilitator superfamily domain, general substrate transporter (1);	3.403760	0.00604	N	0.000398	T	0.63988	0.2558	L	0.36672	1.1	0.09310	N	1	B	0.19073	0.033	B	0.23150	0.044	T	0.37220	-0.9715	10	0.33940	T	0.23	.	0.5222	0.00614	0.4125:0.1743:0.141:0.2723	.	237	Q86UG4	SO6A1_HUMAN	A	237	ENSP00000421339:T237A;ENSP00000369135:T237A	ENSP00000369135:T237A	T	-	1	0	SLCO6A1	101841372	0.009000	0.17119	0.000000	0.03702	0.121000	0.20230	-0.024000	0.12435	-0.981000	0.03520	0.482000	0.46254	ACT	SLCO6A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000370335.1	388.507526	KEEP	NA	-	389.308334	0.438525	107	137	---	---	---	---	1	1	334	450	2	927	119	157	0	271	7	TP
ZFP57	346171	broad.mit.edu	37	6	29640903	29640903	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr6:29640903A>G	ENST00000376883.1	-	6	1336	c.925T>C	c.(925-927)Tcc>Ccc	p.S309P	ZFP57_ENST00000376881.3_Missense_Mutation_p.S309P|ZFP57_ENST00000488757.1_Missense_Mutation_p.S329P			Q9NU63	ZFP57_HUMAN	ZFP57 zinc finger protein	245		NA		NA	DNA methylation involved in embryo development|regulation of gene expression by genetic imprinting|transcription, DNA-dependent		DNA binding|zinc ion binding			NS(1)|autonomic_ganglia(1)|breast(1)|central_nervous_system(3)|cervix(1)|endometrium(2)|large_intestine(5)|liver(1)|lung(16)|ovary(4)|skin(4)|urinary_tract(5)	44						GGTTCCTGGGACCTGGCCACT	0.562	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													119	132	128	NA		NA	NA	6		NA											NA				29640903		1218	2506	3724	SO:0001583	missense	NA	NA	ENSG00000204644	HGNC:18791	XM_294093	Approved	uc011dlw.2	NA	B0S894|B0V254|B2RXJ7|Q5SSB1	ENST00000376883.1	37		.	.	.	.	.	.	.	.	.	.	A	12.02	1.813512	0.32053	.	.	ENSG00000204644	ENST00000488757;ENST00000376881;ENST00000376883	T;T;T	0.05786	3.39;3.62;3.62	4.17	-4.24	0.03777	.	1.561250	0.04080	N	0.309418	T	0.01661	0.0053	L	0.40543	1.245	0.09310	N	1	B;B	0.17268	0.021;0.021	B;B	0.13407	0.009;0.009	T	0.49000	-0.8984	10	0.87932	D	0	-0.9944	3.7375	0.08517	0.3519:0.2624:0.0:0.3858	.	329;309	Q9NU63-3;Q9NU63-2	.;.	P	329;309;309	ENSP00000418259:S329P;ENSP00000366078:S309P;ENSP00000366080:S309P	ENSP00000366078:S309P	S	-	1	0	ZFP57	29748882	0.001000	0.12720	0.001000	0.08648	0.007000	0.05969	-0.029000	0.12329	-0.717000	0.04955	-0.490000	0.04691	TCC	ZFP57-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000132460.2	195.107736	KEEP	NA	-	198.160266	0.358382	62	111	---	---	---	---	1	1	518	732	4	1328	67	123	1	235	10	TP
RSPO3	84870	broad.mit.edu	37	6	127471594	127471594	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr6:127471594T>A	ENST00000356698.4	+	3	902	c.313T>A	c.(313-315)Tgt>Agt	p.C105S	RSPO3_ENST00000368317.3_Missense_Mutation_p.C105S|RSPO3_ENST00000485757.1_3'UTR	NM_032784.3	NP_116173.2	Q9BXY4	RSPO3_HUMAN	R-spondin 3	105		NA		NA		extracellular region	heparin binding		PTPRK/RSPO3(10)	breast(1)|cervix(1)|endometrium(3)|large_intestine(3)|lung(8)|skin(1)	17				GBM - Glioblastoma multiforme(226;0.0555)		CTGTGATACCTGTTTCAACAA	0.373	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													80	80	80	NA		NA	NA	6		NA											NA				127471594		2203	4299	6502	SO:0001583	missense	NA	NA	ENSG00000146374	HGNC:20866	NM_032784	Approved	uc003qar.3	NA	B2RC27|Q5VTV4|Q96K87	ENST00000356698.4	37	CCDS5135.1	.	.	.	.	.	.	.	.	.	.	T	26.6	4.750002	0.89753	.	.	ENSG00000146374	ENST00000356698;ENST00000368317	D;D	0.84516	-1.86;-1.86	5.73	5.73	0.89815	Growth factor, receptor (1);Epidermal growth factor-like (1);	0.000000	0.85682	D	0.000000	D	0.93739	0.7999	M	0.94063	3.49	0.80722	D	1	D;D	0.89917	1.0;0.999	D;D	0.85130	0.997;0.991	D	0.95193	0.8310	10	0.87932	D	0	-27.755	16.3143	0.82909	0.0:0.0:0.0:1.0	.	105;105	Q9BXY4-2;Q9BXY4	.;RSPO3_HUMAN	S	105	ENSP00000349131:C105S;ENSP00000357300:C105S	ENSP00000349131:C105S	C	+	1	0	RSPO3	127513287	1.000000	0.71417	0.999000	0.59377	0.994000	0.84299	7.997000	0.88414	2.313000	0.78055	0.454000	0.30748	TGT	RSPO3-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000042111.1	200.73355	KEEP	NA	+	201.086085	0.446043	62	77	---	---	---	---	1	1	96	154	0	8	68	91	0	149	2	TP
ANGPT1	284	broad.mit.edu	37	8	108334165	108334165	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr8:108334165T>C	ENST00000520734.1	-	3	452	c.167A>G	c.(166-168)gAc>gGc	p.D56G	ANGPT1_ENST00000520052.1_Missense_Mutation_p.D56G|ANGPT1_ENST00000518386.1_5'UTR			Q15389	ANGP1_HUMAN	angiopoietin 1	256		NA		NA	activation of transmembrane receptor protein tyrosine kinase activity|anti-apoptosis|blood coagulation|cell differentiation|heparin biosynthetic process|leukocyte migration|negative regulation of cell adhesion|negative regulation of endothelial cell apoptosis|negative regulation of vascular permeability|positive chemotaxis|positive regulation of blood vessel endothelial cell migration|positive regulation of ERK1 and ERK2 cascade|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of protein kinase B signaling cascade|positive regulation of protein ubiquitination|positive regulation of receptor internalization|protein localization at cell surface|regulation of satellite cell proliferation|sprouting angiogenesis|Tie receptor signaling pathway	extracellular space|membrane raft|microvillus|plasma membrane	receptor tyrosine kinase binding			NS(1)|breast(2)|endometrium(4)|kidney(4)|large_intestine(6)|lung(13)|ovary(4)|prostate(1)|skin(7)|upper_aerodigestive_tract(1)	43	Breast(1;5.06e-08)		OV - Ovarian serous cystadenocarcinoma(57;5.53e-09)			GTGGACTGTGTCCATCAGCTC	0.388	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													184	169	174	NA		NA	NA	8		NA											NA				108334165		2203	4300	6503	SO:0001583	missense	NA	NA	ENSG00000154188	HGNC:484	NM_001146, NM_139290	Approved	uc003ymn.3	NA		ENST00000520734.1	37		.	.	.	.	.	.	.	.	.	.	T	18.56	3.651277	0.67472	.	.	ENSG00000154188	ENST00000517746;ENST00000297450;ENST00000395820;ENST00000520734;ENST00000520052	T;T;T;T	0.53857	0.94;0.94;0.6;0.6	5.36	5.36	0.76844	.	0.092974	0.64402	D	0.000001	T	0.51346	0.1669	M	0.61703	1.905	0.58432	D	0.999999	P;P;P	0.41420	0.469;0.749;0.749	B;B;B	0.38880	0.205;0.284;0.284	T	0.53795	-0.8388	10	0.37606	T	0.19	.	15.3547	0.74418	0.0:0.0:0.0:1.0	.	56;256;256	E7ERK4;Q5HYA0;Q15389	.;.;ANGP1_HUMAN	G	256;256;68;56;56	ENSP00000428340:D256G;ENSP00000297450:D256G;ENSP00000430750:D56G;ENSP00000429349:D56G	ENSP00000297450:D256G	D	-	2	0	ANGPT1	108403341	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	7.376000	0.79658	2.027000	0.59764	0.533000	0.62120	GAC	ANGPT1-002	PUTATIVE	alternative_5_UTR|basic	protein_coding	NA	protein_coding	OTTHUMT00000380428.2	-9.317814	KEEP	NA	-	28.798238	0.058824	11	176	---	---	---	---	1	0.9999979	73	1423	4	1062	13	223	0	232	14	TP
TLL2	7093	broad.mit.edu	37	10	98155083	98155083	+	Silent	SNP	C	C	T	rs151335014		GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr10:98155083C>T	ENST00000357947.3	-	13	1812	c.1587G>A	c.(1585-1587)acG>acA	p.T529T	TLL2_ENST00000469598.1_5'UTR	NM_012465.3	NP_036597.1	Q9Y6L7	TLL2_HUMAN	tolloid-like 2	529	CUB 2.	NA		NA	cell differentiation|multicellular organismal development|proteolysis	extracellular region	calcium ion binding|metalloendopeptidase activity|zinc ion binding	p.T529T(1)		NS(1)|breast(3)|endometrium(3)|haematopoietic_and_lymphoid_tissue(3)|kidney(5)|large_intestine(15)|lung(22)|ovary(1)|pancreas(1)|prostate(1)|skin(3)	58		Colorectal(252;0.0846)		Epithelial(162;1.51e-07)|all cancers(201;7.59e-06)		CACTCTCTTCCGTGGGGCCAT	0.527	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				1	Substitution - coding silent(1)	lung(1)								1,4405	2.1+/-5.4	0,1,2202	72	73	73	NA	1587	-10.7	0	10	dbSNP_134	73	0,8600		0,0,4300	no	coding-synonymous	TLL2	NM_012465.3		0,1,6502	TT,TC,CC	NA	0.0,0.0227,0.0077		529/1016	98155083	1,13005	2203	4300	6503	SO:0001819	synonymous_variant	NA	NA	ENSG00000095587	HGNC:11844		Approved	uc001kml.2	NA	A6NDK0|Q2M1H1|Q6PJN5|Q9UQ00	ENST00000357947.3	37	CCDS7449.1																																																																																			TLL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049608.1	95.91264	KEEP	NA	-	96.629299	0.397436	31	47	---	---	---	---	1	1	196	289	0	456	40	57	0	135	2	TP
SLC22A11	55867	broad.mit.edu	37	11	64329818	64329818	+	Silent	SNP	G	G	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr11:64329818G>A	ENST00000301891.4	+	4	1106	c.732G>A	c.(730-732)gcG>gcA	p.A244A	SLC22A11_ENST00000377581.3_Silent_p.A244A|SLC22A11_ENST00000490834.1_3'UTR|SLC22A11_ENST00000377585.3_Silent_p.A244A	NM_018484.2	NP_060954.1	Q9NSA0	S22AB_HUMAN	solute carrier family 22 (organic anion/urate transporter), member 11	244		NA		NA	urate metabolic process	apical plasma membrane|external side of plasma membrane|integral to plasma membrane	inorganic anion exchanger activity|protein binding|sodium-independent organic anion transmembrane transporter activity			breast(1)|central_nervous_system(3)|endometrium(3)|kidney(2)|large_intestine(5)|lung(6)|ovary(1)|pancreas(1)|upper_aerodigestive_tract(1)	23					Probenecid(DB01032)	GCCAGGCGGCGCTGGGCGGCC	0.632	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													66	70	68	NA		NA	NA	11		NA											NA				64329818		2201	4297	6498	SO:0001819	synonymous_variant	NA	NA	ENSG00000168065	HGNC:18120	NM_018484	Approved	uc001oai.3	NA	A8K426|Q53GR2|Q6ZP72|Q8NBU4	ENST00000301891.4	37	CCDS8074.1																																																																																			SLC22A11-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000104886.4	-23.091108	KEEP	NA	+	17.725134	0.052083	10	182	---	---	---	---	1	1	84	1723	2	1968	12	214	0	244	7	TP
KRT1	3848	broad.mit.edu	37	12	53072470	53072470	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr12:53072470G>T	ENST00000252244.3	-	2	720	c.662C>A	c.(661-663)tCc>tAc	p.S221Y		NM_006121.3	NP_006112.3	P04264	K2C1_HUMAN	keratin 1	221	Linker 1.|Rod.	NA		NA	complement activation, lectin pathway|epidermis development|fibrinolysis|regulation of angiogenesis|response to oxidative stress	plasma membrane	protein binding|receptor activity|structural constituent of cytoskeleton|sugar binding			breast(2)|central_nervous_system(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(7)|lung(11)|ovary(1)|prostate(7)|skin(3)	39						GGTTCTAGTGGAGGTATCTAC	0.468	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													109	100	103	NA		NA	NA	12		NA											NA				53072470		2203	4300	6503	SO:0001583	missense	NA	NA	ENSG00000167768	HGNC:6412		Approved	uc001sau.1	NA	B2RA01|Q14720|Q6GSJ0|Q9H298	ENST00000252244.3	37	CCDS8836.1	.	.	.	.	.	.	.	.	.	.	G	18.61	3.660978	0.67700	.	.	ENSG00000167768	ENST00000252244	D	0.84589	-1.87	4.78	4.78	0.61160	Filament (1);	.	.	.	.	D	0.92652	0.7665	M	0.86343	2.81	0.09310	N	1	D	0.69078	0.997	D	0.73380	0.98	D	0.85629	0.1269	9	0.72032	D	0.01	.	12.651	0.56761	0.0801:0.0:0.9199:0.0	.	221	P04264	K2C1_HUMAN	Y	221	ENSP00000252244:S221Y	ENSP00000252244:S221Y	S	-	2	0	KRT1	51358737	0.011000	0.17503	0.021000	0.16686	0.197000	0.23852	1.773000	0.38563	2.370000	0.80446	0.643000	0.83706	TCC	KRT1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000405706.1	148.57476	KEEP	NA	-	149.041024	0.433333	52	68	---	---	---	---	1	1	343	457	3	642	64	75	0	175	11	TP
PSMC5	5705	broad.mit.edu	37	17	61908445	61908445	+	Silent	SNP	A	A	G			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr17:61908445A>G	ENST00000310144.6	+	8	1037	c.729A>G	c.(727-729)ccA>ccG	p.P243P	PSMC5_ENST00000375812.4_Silent_p.P235P|PSMC5_ENST00000581882.1_Silent_p.P235P|PSMC5_ENST00000580864.1_Silent_p.P235P|FTSJ3_ENST00000580295.1_5'Flank	NM_002805.5	NP_002796.4	P62195	PRS8_HUMAN	proteasome (prosome, macropain) 26S subunit, ATPase, 5	243		NA		NA	anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process|apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|G1/S transition of mitotic cell cycle|M/G1 transition of mitotic cell cycle|mRNA metabolic process|negative regulation of programmed cell death|negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|positive regulation of transcription, DNA-dependent|positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle|regulation of apoptosis|regulation of cellular amino acid metabolic process|S phase of mitotic cell cycle|transcription from RNA polymerase II promoter|viral reproduction	cytoplasm|nucleus|proteasome complex	ATP binding|ATPase activity|thyrotropin-releasing hormone receptor binding|transcription cofactor activity|transcription factor binding			endometrium(3)|kidney(2)|large_intestine(8)|lung(3)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1)	20						AACATGCTCCATCTATCATCT	0.562	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													92	88	89	NA		NA	NA	17		NA											NA				61908445		2203	4300	6503	SO:0001819	synonymous_variant	NA	NA	ENSG00000087191	HGNC:9552	NM_002805	Approved	uc002jcb.3	NA	A8K763|O35051|O43208|P47210|P52915|P52916	ENST00000310144.6	37	CCDS11645.1																																																																																			PSMC5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000444404.1	-25.080809	KEEP	NA	+	11.962109	0.0375	6	154	---	---	---	---	1	0.9985648	69	1234	4	1103	7	186	0	171	12	TP
MUC16	94025	broad.mit.edu	37	19	9026313	9026313	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr19:9026313C>A	ENST00000397910.4	-	14	36876	c.36673G>T	c.(36673-36675)Gct>Tct	p.A12225S		NM_024690.2	NP_078966.2	Q8WXI7	MUC16_HUMAN	mucin 16, cell surface associated	12227		NA		NA	cell adhesion	extracellular space|extrinsic to membrane|integral to membrane|plasma membrane	protein binding			NS(9)|autonomic_ganglia(1)|breast(26)|central_nervous_system(11)|cervix(1)|endometrium(46)|haematopoietic_and_lymphoid_tissue(5)|kidney(35)|large_intestine(91)|liver(1)|lung(278)|ovary(17)|pancreas(2)|prostate(17)|skin(18)|soft_tissue(1)|stomach(8)|upper_aerodigestive_tract(16)|urinary_tract(7)	590						AGAGGGCCAGCAGCTATAGTG	0.438	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													179	162	167	NA		NA	NA	19		NA											NA				9026313		2023	4190	6213	SO:0001583	missense	NA	NA		HGNC:15582	NM_024690	Approved	uc002mkp.3	NA	Q6ZQW5|Q96RK2	ENST00000397910.4	37	CCDS54212.1	.	.	.	.	.	.	.	.	.	.	c	6.579	0.475153	0.12521	.	.	ENSG00000181143	ENST00000397910	T	0.33438	1.41	2.35	-4.7	0.03288	.	.	.	.	.	T	0.21761	0.0524	M	0.70595	2.14	.	.	.	P	0.44344	0.833	B	0.32022	0.139	T	0.07751	-1.0756	8	0.87932	D	0	.	4.0701	0.09879	0.0:0.2406:0.3565:0.403	.	12225	B5ME49	.	S	12225	ENSP00000381008:A12225S	ENSP00000381008:A12225S	A	-	1	0	MUC16	8887313	0.000000	0.05858	0.000000	0.03702	0.012000	0.07955	-3.457000	0.00464	-1.231000	0.02557	0.195000	0.17529	GCT	MUC16-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402806.1	-45.664315	KEEP	NA	-	10.640006	0.026432	6	221	---	---	---	---	1	0.9702669	22	1173	2	816	6	256	0	227	12	TP
ZNF665	79788	broad.mit.edu	37	19	53669083	53669083	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr19:53669083G>C	ENST00000600412.1	-	2	580	c.465C>G	c.(463-465)aaC>aaG	p.N155K	CTD-2245F17.2_ENST00000600257.1_RNA|ZNF665_ENST00000396424.3_Missense_Mutation_p.N220K			Q9H7R5	ZN665_HUMAN	zinc finger protein 665	155		NA		NA	regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|endometrium(2)|kidney(2)|large_intestine(10)|lung(16)|ovary(2)|prostate(1)|upper_aerodigestive_tract(1)	35				GBM - Glioblastoma multiforme(134;0.0196)		GGATTGTTAGGTTTGAACGAA	0.403	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													117	126	123	NA		NA	NA	19		NA											NA				53669083		2203	4300	6503	SO:0001583	missense	NA	NA		HGNC:25885	NM_024733	Approved	uc010eqm.1	NA	A8K5T8	ENST00000600412.1	37		.	.	.	.	.	.	.	.	.	.	G	4.303	0.055547	0.08291	.	.	ENSG00000197497	ENST00000396424	T	0.35421	1.31	2.44	-3.67	0.04476	.	.	.	.	.	T	0.19446	0.0467	L	0.39692	1.235	0.09310	N	1	P	0.41450	0.75	B	0.35550	0.205	T	0.22626	-1.0211	9	0.16420	T	0.52	.	5.013	0.14322	0.5174:0.1589:0.3237:0.0	.	220	Q9H7R5-2	.	K	220	ENSP00000379702:N220K	ENSP00000379702:N220K	N	-	3	2	ZNF665	58360895	0.000000	0.05858	0.000000	0.03702	0.003000	0.03518	-0.298000	0.08265	-0.650000	0.05423	-0.385000	0.06624	AAC	ZNF665-002	PUTATIVE	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000464179.1	-22.89976	KEEP	NA	-	21.64075	0.044776	9	192	---	---	---	---	1	0.9999999	52	1020	0	1479	9	212	0	231	2	TP
NCOA3	8202	broad.mit.edu	37	20	46271028	46271028	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr20:46271028G>T	ENST00000372004.3	+	17	3368	c.3152G>T	c.(3151-3153)aGa>aTa	p.R1051I	NCOA3_ENST00000371997.3_Missense_Mutation_p.R1046I|NCOA3_ENST00000371998.3_Missense_Mutation_p.R1051I|NCOA3_ENST00000341724.6_Missense_Mutation_p.R981I	NM_001174087.1|NM_001174088.1|NM_006534.3|NM_181659.2	NP_001167558.1|NP_001167559.1|NP_006525.2|NP_858045.1	Q9Y6Q9	NCOA3_HUMAN	nuclear receptor coactivator 3	1051	Interaction with CREBBP.	NA		NA	androgen receptor signaling pathway|cellular lipid metabolic process|positive regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent	nucleoplasm	androgen receptor binding|histone acetyltransferase activity|ligand-dependent nuclear receptor binding|protein N-terminus binding|signal transducer activity|thyroid hormone receptor binding			breast(3)|endometrium(3)|kidney(4)|large_intestine(12)|lung(19)|ovary(4)|prostate(2)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(1)	52						AGTGACGAAAGAGCATTATTG	0.473	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0													170	153	159	NA		NA	NA	20		NA											NA				46271028		2203	4300	6503	SO:0001583	missense	NA	NA	ENSG00000124151	HGNC:7670	NM_006534	Approved	uc002xtk.3	NA	A4LAZ5|Q0VF45|Q5JYD9|Q5JYE0|Q9BR49|Q9UPC9|Q9UPG4|Q9UPG7	ENST00000372004.3	37	CCDS13406.1	.	.	.	.	.	.	.	.	.	.	G	16.13	3.036195	0.54896	.	.	ENSG00000124151	ENST00000340189;ENST00000341724;ENST00000372004;ENST00000371998;ENST00000371997	T;T;T;T	0.02606	4.25;4.4;4.4;4.23	5.62	4.67	0.58626	Nuclear receptor coactivator, interlocking (1);Nuclear receptor coactivator, Ncoa-type, interlocking (1);	0.238888	0.39834	N	0.001259	T	0.02848	0.0085	N	0.19112	0.55	0.80722	D	1	B;B;B;B;B;B	0.28026	0.087;0.198;0.045;0.045;0.036;0.045	B;B;B;B;B;B	0.33690	0.117;0.133;0.168;0.117;0.071;0.168	T	0.54918	-0.8221	10	0.52906	T	0.07	-16.0584	9.5999	0.39598	0.071:0.0:0.7878:0.1412	.	1051;1046;1055;1051;1051;1051	A8K0W8;Q9Y6Q9-3;Q59EE8;Q0IIN7;Q9Y6Q9-5;Q9Y6Q9	.;.;.;.;.;NCOA3_HUMAN	I	1051;981;1051;1051;1046	ENSP00000342123:R981I;ENSP00000361073:R1051I;ENSP00000361066:R1051I;ENSP00000361065:R1046I	ENSP00000345671:R1051I	R	+	2	0	NCOA3	45704435	1.000000	0.71417	0.999000	0.59377	0.752000	0.42762	6.259000	0.72494	1.512000	0.48834	0.650000	0.86243	AGA	NCOA3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000080403.3	-4.190273	KEEP	NA	+	23.346837	0.074324	11	137	---	---	---	---	1	1	114	1216	0	1500	11	147	0	157	2	TP
PREX1	57580	broad.mit.edu	37	20	47266679	47266679	+	Silent	SNP	C	C	T			GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid	Somatic	Phase_I	WXS	none,targeted,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-06-0221-Tumor-SM-1QUO6	GBM-TCGA-06-0221-Normal-SM-1QUMY	g.chr20:47266679C>T	ENST00000396220.1	-	24	2905	c.2883G>A	c.(2881-2883)ccG>ccA	p.P961P	PREX1_ENST00000371941.3_Silent_p.P961P			Q8TCU6	PREX1_HUMAN	phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1	961		NA		NA	actin filament polymerization|apoptosis|induction of apoptosis by extracellular signals|nerve growth factor receptor signaling pathway|neutrophil activation|small GTPase mediated signal transduction|superoxide metabolic process	cytosol|plasma membrane	enzyme binding|phospholipid binding|Rho GTPase activator activity|Rho guanyl-nucleotide exchange factor activity			breast(3)|central_nervous_system(1)|endometrium(4)|kidney(6)|large_intestine(27)|lung(53)|ovary(3)|pancreas(1)|prostate(1)|skin(2)|stomach(5)|upper_aerodigestive_tract(3)|urinary_tract(1)	110			BRCA - Breast invasive adenocarcinoma(12;0.0135)|Colorectal(8;0.198)			GGCCACACAGCGGGTGGGGCT	0.592	NA	NA		NA		NA		NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA			NA				0								C		0,4406		0,0,2203	83	92	89	NA	2883	-11.4	0	20		89	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	PREX1	NM_020820.3		0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077		961/1660	47266679	1,13005	2203	4300	6503	SO:0001819	synonymous_variant	NA	NA	ENSG00000124126	HGNC:32594	NM_020820	Approved	uc002xtw.1	NA	E1P5X9|Q5JS95|Q5JS96|Q69YL2|Q7Z2L9|Q9BQH0|Q9BX55|Q9H4Q6|Q9P2D2|Q9UGQ4	ENST00000396220.1	37																																																																																				PREX1-201	KNOWN	basic	protein_coding	NA	protein_coding		-18.754339	KEEP	NA	-	25.567831	0.056075	12	202	---	---	---	---	1	1	41	969	0	792	13	249	0	268	2	TP
